FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2080642151> ?p ?o ?g. }

• W2080642151 abstract "Chinese translation Background: Medicare Part D and the U.S. Department of Veterans Affairs (VA) use different approaches to manage prescription drug benefits, with implications for spending. Medicare relies on private plans with distinct formularies, whereas the VA administers its own benefit using a national formulary. Objective: To compare overall and regional rates of brand-name drug use among older adults with diabetes in Medicare and the VA. Design: Retrospective cohort. Setting: Medicare and the VA, 2008. Patients: 1 061 095 Medicare Part D beneficiaries and 510 485 veterans aged 65 years or older with diabetes. Measurements: Percentage of patients taking oral hypoglycemics, statins, and angiotensin-converting enzyme (ACE) inhibitors or angiotensin-receptor blockers (ARBs) who filled brand-name drug prescriptions and percentage of patients taking long-acting insulins who filled analogue prescriptions. Sociodemographic- and health status–adjusted hospital referral region (HRR) brand-name drug use was compared, and changes in spending were calculated if use of brand-name drugs in 1 system mirrored the other. Results: Brand-name drug use in Medicare was 2 to 3 times that in the VA: 35.3% versus 12.7% for oral hypoglycemics, 50.7% versus 18.2% for statins, 42.5% versus 20.8% for ACE inhibitors or ARBs, and 75.1% versus 27.0% for insulin analogues. Adjusted HRR-level brand-name statin use ranged (from the 5th to 95th percentiles) from 41.0% to 58.3% in Medicare and 6.2% to 38.2% in the VA. For each drug group, the 95th-percentile HRR in the VA had lower brand-name drug use than the 5th-percentile HRR in Medicare. Medicare spending in this population would have been $1.4 billion less if brand-name drug use matched that of the VA. Limitation: This analysis cannot fully describe the factors underlying differences in brand-name drug use. Conclusion: Medicare beneficiaries with diabetes use 2 to 3 times more brand-name drugs than a comparable group within the VA, at substantial excess cost. Primary Funding Source: U.S. Department of Veterans Affairs, National Institutes of Health, and Robert Wood Johnson Foundation." @default.
• W2080642151 created "2016-06-24" @default.
• W2080642151 creator A5010861527 @default.
• W2080642151 creator A5012227398 @default.
• W2080642151 creator A5019109829 @default.
• W2080642151 creator A5019670773 @default.
• W2080642151 creator A5039605963 @default.
• W2080642151 creator A5045241161 @default.
• W2080642151 creator A5058147391 @default.
• W2080642151 creator A5068379220 @default.
• W2080642151 creator A5086325206 @default.
• W2080642151 date "2013-06-11" @default.
• W2080642151 modified "2023-10-16" @default.
• W2080642151 title "Brand-Name Prescription Drug Use Among Veterans Affairs and Medicare Part D Patients With Diabetes" @default.
• W2080642151 cites W1529223681 @default.
• W2080642151 cites W1766020230 @default.
• W2080642151 cites W1871828706 @default.
• W2080642151 cites W1953393606 @default.
• W2080642151 cites W1966663730 @default.
• W2080642151 cites W1968670396 @default.
• W2080642151 cites W1974225901 @default.
• W2080642151 cites W1979721777 @default.
• W2080642151 cites W1981820962 @default.
• W2080642151 cites W1984959392 @default.
• W2080642151 cites W1989247444 @default.
• W2080642151 cites W1990136122 @default.
• W2080642151 cites W1998043752 @default.
• W2080642151 cites W2006510560 @default.
• W2080642151 cites W2025735349 @default.
• W2080642151 cites W2033136851 @default.
• W2080642151 cites W2036483116 @default.
• W2080642151 cites W2038569187 @default.
• W2080642151 cites W2040739950 @default.
• W2080642151 cites W2041382570 @default.
• W2080642151 cites W2043128333 @default.
• W2080642151 cites W2044846641 @default.
• W2080642151 cites W2058062543 @default.
• W2080642151 cites W2063061134 @default.
• W2080642151 cites W2064016431 @default.
• W2080642151 cites W2067032911 @default.
• W2080642151 cites W2068657668 @default.
• W2080642151 cites W2073036176 @default.
• W2080642151 cites W2093131224 @default.
• W2080642151 cites W2097130565 @default.
• W2080642151 cites W2097535361 @default.
• W2080642151 cites W2097971807 @default.
• W2080642151 cites W2108553564 @default.
• W2080642151 cites W2122860570 @default.
• W2080642151 cites W2128788812 @default.
• W2080642151 cites W2129168200 @default.
• W2080642151 cites W2134726862 @default.
• W2080642151 cites W2160862999 @default.
• W2080642151 cites W2330463600 @default.
• W2080642151 cites W3125216057 @default.
• W2080642151 cites W48263616 @default.
• W2080642151 doi "https://doi.org/10.7326/0003-4819-159-2-201307160-00664" @default.
• W2080642151 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3787067" @default.
• W2080642151 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23752663" @default.
• W2080642151 hasPublicationYear "2013" @default.
• W2080642151 type Work @default.
• W2080642151 sameAs 2080642151 @default.
• W2080642151 citedByCount "25" @default.
• W2080642151 countsByYear W20806421512014 @default.
• W2080642151 countsByYear W20806421512015 @default.
• W2080642151 countsByYear W20806421512016 @default.
• W2080642151 countsByYear W20806421512017 @default.
• W2080642151 countsByYear W20806421512018 @default.
• W2080642151 countsByYear W20806421512019 @default.
• W2080642151 countsByYear W20806421512022 @default.
• W2080642151 crossrefType "journal-article" @default.
• W2080642151 hasAuthorship W2080642151A5010861527 @default.
• W2080642151 hasAuthorship W2080642151A5012227398 @default.
• W2080642151 hasAuthorship W2080642151A5019109829 @default.
• W2080642151 hasAuthorship W2080642151A5019670773 @default.
• W2080642151 hasAuthorship W2080642151A5039605963 @default.
• W2080642151 hasAuthorship W2080642151A5045241161 @default.
• W2080642151 hasAuthorship W2080642151A5058147391 @default.
• W2080642151 hasAuthorship W2080642151A5068379220 @default.
• W2080642151 hasAuthorship W2080642151A5086325206 @default.
• W2080642151 hasBestOaLocation W20806421512 @default.
• W2080642151 hasConcept C100406419 @default.
• W2080642151 hasConcept C126322002 @default.
• W2080642151 hasConcept C134018914 @default.
• W2080642151 hasConcept C160735492 @default.
• W2080642151 hasConcept C162324750 @default.
• W2080642151 hasConcept C167135981 @default.
• W2080642151 hasConcept C194828623 @default.
• W2080642151 hasConcept C2426938 @default.
• W2080642151 hasConcept C2775969662 @default.
• W2080642151 hasConcept C2776135927 @default.
• W2080642151 hasConcept C2776291444 @default.
• W2080642151 hasConcept C2778829437 @default.
• W2080642151 hasConcept C2778858636 @default.
• W2080642151 hasConcept C50522688 @default.
• W2080642151 hasConcept C512399662 @default.
• W2080642151 hasConcept C555293320 @default.
• W2080642151 hasConcept C71924100 @default.
• W2080642151 hasConcept C72563966 @default.
• W2080642151 hasConcept C98274493 @default.
• W2080642151 hasConceptScore W2080642151C100406419 @default.

• next